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In tro duc tion: Tour niquet due ve nous sta sis can al ter bo th con cen tra tion and/or ac ti vi ty of se ve ral blood ana lytes, but is ra re ly re gar ded as an is sue 
of la bo ra to ry va ria bi li ty. To over co me the prob lem tran sil lu mi na tion de vi ces (TD) ha ve been pro po sed for a sta si s-free phle bo to my. In this pa per the 
use of a TD in pla ce of tour niquet du ri ng blood col lec tion has been eva lua ted.
Ma te ria ls and met ho ds: Blood was col lec ted from 250 vo lun tee rs di vi ded in fi  ve ho mo ge nous grou ps of tour niquet ti mes (G1: 30 sec, G2: 60 sec, 
G3: 90 sec, G4: 120 sec, G5: 180 sec) and com pa red to blood ob tai ned usi ng TD. All sam ples we re ana lyzed for glu co se (GLU), total pro tein (TP), albu-
min (ALB), trig lyce ri des (TRIG), potas sium (K), sodium (NA), phos pha te (PHOS), cal cium (CA), alka li ne phos pha ta se (ALKP) and mag ne sium (MG).
Re sul ts: In res pe ct of TD, G1 did not show sta tis ti cal ly sig ni fi  ca nt in crea ses in all cli ni cal che mis try tes ts; G2 showed in crea ses for GLU, TP, ALB, TRIG, K, 
CA, MG and ALKP. G3 and G4, showed no sig ni fi  ca nt in crea se on ly for PHOS. G5 showed sig ni fi  ca nt in crea ses in all the tes ts eva lua ted. Mo reo ver, cli ni cal ly 
sig ni fi  ca nt va ria tio ns we re ob ser ved for TP, ALB, K and CA in G2 to G5; for NA in G3 to G5; for MG in G4 and G5; for GLU, TRIG, ALKP on ly in G5.
Con clu sio ns: The se re sul ts sup po rt the ap pli ca tion of TD in blood col lec tion for rou ti ne cli ni cal che mis try la bo ra to ry tes ts, sug ges ti ng its use shou ld 
be mo re diff u sed.
Key wor ds: phle bo to my and blood col lec tion; pre ana lyti cal pha se; qua li ty ma na ge me nt system in cli ni cal la bo ra to ry; tran sil lu mi na tion; ve nous 
sta sis.
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Original article
In tro duc tion
Se ve ral li nes of evi den ces at te st that the pre ana-
lyti cal pha se is res pon sib le for mo re than two thir-
ds of all er ro rs ari si ng from the to tal tes ti ng pro ce-
ss (1-4). The re are on ly few rou ti ne pro ce du res for 
the de tec tion of no n-con for mi ties in this fi e ld of 
ac ti vi ty (5,6). In this pha se the pro ce du res in vol vi-
ng phle bo to my, cri ti cal to the ob tain me nt of diag-
nos tic blood spe ci me ns, are poor ly stu died as re-
gar ds the ma jor sour ces of er ro rs and the pro ce du-
res re la ted to qua li ty con trol pro ce ss (7,8). Des pi te 
sig ni fi  ca nt im pro ve men ts in blood sam pli ng 
equip men ts and pro ce du res du ri ng the la st two 
de ca des (e.g. po si ti ve pa tie nt iden ti fi  ca tion, va-
cuum tu bes for blood sam pli ng, im pro ved need-
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les for phle bo to my and ope ra tor sa fe ty, amo ng ot-
he rs), it is sti ll im por ta nt to em pha si ze that pro ce-
du res of phle bo to my need atten tion and a mo re 
ca re ful and syste ma tic su per vi sion in or der to pre-
ve nt er ro rs (9). The col lec tion of diag nos tic blood 
spe ci me ns for cli ni cal bioc he mis try tes ts is tra di-
tio nal ly per for med by phle bo to mis ts usi ng a tour-
niquet for evi den ci ng vei ns (10). The Cli ni cal and 
La bo ra to ry Stan dar ds In sti tu te (CLSI), for mer ly 
known as Na tio nal Com mit tee for Cli ni cal La bo ra-
to ry Stan dar ds (NCCLS), re com men ds the use of 
the tour niquet for lo ca li zi ng sui tab le vei ns and the 
tour niquet ti me can not in any ca se be exten ded 
over 60 se con ds. When per for mi ng spe ci men col-
lec tion for diag nos tic pur po ses su ch an in ter val of 
ti me is con si de red sui tab le for bo th ea si ng lo ca li-
za tion of vein pat hs and con co mi tan tly cir cum ven-
ti ng pos sib le prob le ms due to ve nous sta sis (11,12). 
As su ch, al thou gh the ve nous sta sis can in fl uen ce 
the con cen tra tion and/or the ac ti vi ty of se ve ral 
blood ana lytes, the tour niquet ti me is ra re ly re gar-
ded as a po ten tial sour ce of la bo ra to ry va ria bi li ty 
(13-17). Stan da rd pro ce du res no twit hstan di ng, the 
mean tour niquet ap pli ca tion ti me by phle bo to mi-
st re por ted ly was 98 sec in pub lic la bo ra to ries and 
70 sec in pri va te la bo ra to ries res pec ti ve ly, thus ari-
si ng so me is sues about pro per spe ci men col lec-
tion (18). The use of tran sil lu mi na tion de vi ces (TD), 
ba sed on co ld near in fra red lig ht-e mit ti ng dio des 
(LE Ds) who se lig ht is ab sor bed by in tra-e rythro-
cyte hae mog lo bin fl owi ng alo ng the vei ns, has 
been for mer ly pro po sed in or der to ea se the vein 
pun ctu re in chil dren (19). The effi   ca cy of pa lm tran-
sil lu mi na tion for es tab lis hi ng ve nous ac ce ss in 
sma ll in fan ts has al rea dy been as ses sed (20). Mo-
reo ver, the tran sil lu mi na tion has been pro po sed 
for map pi ng vei ns to be can nu la ted prior to am-
bu la to ry phle bo to my, be cau se it wou ld al low a 
mo re ac cu ra te vi sua li za tion of the vein cour se (21). 
Wi th the aim to im pro ve the qua li ty ma na ge me nt 
in prea na lyti cal pha se of the cli ni cal bioc he mis try 
la bo ra to ry, we eva lua ted whet her TD cou ld ad van-
ta geous ly rep la ce the tour niquet du ri ng the pro-
ce du re for col lec tion of diag nos tic blood spe ci me-
ns and the re by com ple te ly eli mi na te the ri sk of 
bias in la bo ra to ry tes ti ng due to ve nous sta sis.
Ma te ria ls and met ho ds
Stu dy de si gn
250 out pa tie nt adul ts of bo th gen de rs, vo lun tee rs 
for this stu dy, from Dan te Paz za ne se Car dio lo gy 
Institu te, São Pau lo ci ty, Bra zil, we re eva lua ted. This 
stu dy was sub mit ted to the In ter nal Re view Boa rd 
and ap pro ved by the lo cal Hu man Re sear ch Et hi cs 
Com mit tee. All vo lun tee rs sig ned an in for med 
con se nt.
Col lec tion of diag nos tic blood spe ci me ns
The col lec tion of diag nos tic blood spe ci me ns was 
ac com plis hed by a sin gle, expe rt phle bo to mi st, 
fol lowi ng the in ter na tio nal stan da rd from CLSI 
(11,12). Fir st, we stu died 50 pa tien ts (G1). All pa tien-
ts, af ter 12-hours fas ti ng, we re main tai ned sea ted 
du ri ng 15 mi nu tes to eli mi na te pos sib le in ter fe ren-
ces of blood dis tri bu tion due to diff e re nt pos tu re 
(22). Af ter this in ter val, a vein was lo ca ted on the 
le ft fo rea rm by a sub cu ta neous tis sue TD (Ve nos-
cópio IV, Duan do Bra sil, Bra zil), and the diag nos tic 
blood sam ple was col lec ted usi ng a 20 G straig ht 
need le (BD Vacuntainer®, Bec ton Dic kin son Diag-
nos ti cs, Fran klin La kes, NJ, USA), di rec tly in to 5 mL 
SST II Advance® va cuum tu bes wi th clot ac ti va tor 
and ac rylic gel se pa ra tor, (BD Vacuntainer®, Bec ton 
Dic kin son Diag nos ti cs, Fran klin La kes, NJ, USA). All 
the tu bes used in this stu dy we re of the sa me lot. 
In sequen ce, a tour niquet was ap plied on the rig ht 
fo rea rm du ri ng 30 sec (11,12), and anot her sam ple 
was col lec ted in to the sa me type of va cuum tu be. 
The ti me in ter val be tween TD and tour niquet 
blood drawing was stan dar di zed to 60 ± 10 sec. 
The stu dy was then con ti nued by eva lua ti ng the 
ot her 4 grou ps (G2, G3, G4 and G5) of 50 diff e re nt 
vo lun tee rs ea ch, and the sa me met ho do lo gy for 
diag nos tic blood sam ple col lec tion was ap plied, 
but the tour niquet ti me va ried as fol lows: in G2 the 
tour niquet was ap plied for 60 sec (ac cep ted stan-
da rd ti me for tour niquet ap plied) (11,12), in G3 for 
90 sec, in G4 for 120 sec and in G5 for 180 sec.
Pro ces si ng of diag nos tic blood spe ci me ns
All the sam ple tu bes we re le ft in up rig ht po si tion 
for 45 min at room tem pe ra tu re (20 °C) to al low 
com ple te blood clot ti ng be fo re cen tri fu ga tion (11). 
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Af ter cen tri fu ga tion at 1500 x g for 10 min at room 
tem pe ra tu re (ac cor di ng to the in struc tio ns of the 
ma nu fac tu rer), se rum was se pa ra ted, sto red in 
aliquo ts and ke pt fro zen at -70 °C un til mea su re-
me nt. All sam ples did not show any si gn of hae-
mo lysis by vi sual in spec tion. No spe ci men was di-
scarded due to un sa tis fac to ry at tem pts, diffi   cul ty 
in lo ca ti ng ve nous ac ce ss, mis si ng vei ns, ma ni fe st 
hae mo lysis or li pae mia.
La bo ra to ry tes ti ng
All se rum aliquo ts we re thawed in sa me ti me. The 
rou ti ne cli ni cal bioc he mis try tes ts we re per for med 
in dup li ca te im me dia te ly af ter thawi ng on the sa-
me in stru me nt VITROS 5,1 FS Che mis try System 
(Or tho-Cli ni cal Diag nos ti cs), ac cor di ng to the ma-
nu fac tu rer’s spe ci fi  ca tio ns and usi ng prop rie ta ry 
rea gen ts. The pa nel of tes ts in clu ded the fol lowi-
ng: glu co se (GLU), total pro tein (TP), albu min (ALB), 
trig lyce ri des (TRIG), potas sium (K), sodium (NA), 
phos pha te (PHOS), cal cium (CA), alka li ne phos pha-
ta se (ALKP) and magne sium (MG). The in stru me nt 
was ca lib ra ted again st ap prop ria te prop rie ta ry re-
fe ren ce stan da rd ma te rial and ve ri fi ed wi th the 
use of prop rie ta ry qua li ty con tro ls. A mul ti cen ter 
eva lua tion of the wit hi n-run pre ci sion of the VIT-
ROS® 5,1 FS Che mis try System showed coeffi   cien ts 
of va ria tion ran gi ng from 1.2% to 1.5% for GLU, from 
1.2% to 2.0% for TP, from 0.9% to 1.7% for ALB, from 
0.9% to 1.4% for TRIG, from 1.21% to 1.25% for K, 
from 0.61% to 0.65% for NA, from 1.5% to 2.4% for 
PHOS, from 1.4% to 1.6% for CA, from 2.1% to 2.4% 
for ALKP, from 1.5% to 2.9% for MG (23).
Sta tis ti cal ana lysis
The sig ni fi  can ce of the diff e ren ces be tween sam-
ples, ta ki ng the va lues from sam ples col lec ted usi-
ng the sub cu ta neous tis sue tran sil lu mi na tor de vi-
ce as the re fe ren ce ones, was as ses sed by pai red 
Stu de nt’s t-te st af ter chec ki ng for nor ma li ty usi ng 
li cen sed sta tis ti cal sof twa re (Grap hPad Prism® ver-
sion 5.01). The le vel of sta tis ti cal sig ni fi  can ce was 
set at P < 0.05. Fi nal ly, the bia ses from G1, G2, G3, 
G4 and G5 we re com pa red wi th the cur re nt de si-
rab le qua li ty spe ci fi  ca tio ns for bias (B), de ri ved from 
bio lo gi cal va ria tion ac cor di ng to the for mu la B < 
0.25 (CVw2 + CVg2)1/2 whe re CVw and CVg are wit hi n- 
and be twee n-sub je ct coeffi   cien ts of va ria tio ns (24)
Re sul ts
The re sul ts of the stu dy are shown in Tab le 1.
Com pa red wi th TD, in G1 no sig ni fi  ca nt in crea ses 
we re ob ser ved for cli ni cal che mis try tes ts eva lua-
ted af ter 30 sec of the tour niquet ap pli ca tion. In 
G2 (i.e., af ter 60 sec of tour niquet), sig ni fi  ca nt in-
crea ses we re ob ser ved for GLU, TP, ALB, TRIG, K, 
CA, MG and ALKP. In G3 and G4, sig ni fi  ca nt in crea-
ses we re ob ser ved for all the pa ra me te rs tes ted 
except PHOS. Fi nal ly, in G5 (af ter 180 sec tour-
niquet ap pli ca tion) sig ni fi  ca nt in crea ses we re ob-
ser ved in all the cli ni cal che mis try tes ts eva lua ted. 
Cli ni cal ly sig ni fi  ca nt va ria tio ns, as com pa red wi th 
the cur re nt de si rab le qua li ty spe ci fi  ca tio ns (24), 
we re howe ver ob ser ved for TP, ALB, K and CA af ter 
60, 90, 120 and 180 sec of sta sis (Group 2, 3, 4 and 
5); for NA af ter 90, 120 and 180 sec of sta sis (Group 
3, 4 and 5); for MG af ter 90 and 180 sec of sta sis 
(Group 4 and 5); for GLU, TRIG and ALKP on ly af ter 
180 sec of sta sis (Group 5).
Dis cus sion
A su per fi  cial knowled ge of the im por tan ce of de-
tai ls su ch as a) adequa te fas ti ng ti me be fo re blood 
col lec tion (25); b) use of ap prop ria te tu bes (26-28) 
and ad di ti ves (29); c) fac to rs clo se ly as so cia ted wi-
th the spe ci men col lec tion, su ch as la ck of ful fi l li ng 
the ri go rous cri te ria of cor re ct blood drawi ng, use 
of tu bes con tai ni ng diff e re nt ad di ti ve pro-coa gu-
lan ts, in com ple te fi l li ng or ina dequa te mixi ng of 
the tu bes (30-32); d) tem pe ra tu re and ti me be fo re 
cen tri fu ga tion (33); e) la ck of con for mi ty to the re-
com men da tio ns re gar di ng tour niquet ti me (15-
17,34) are ab le by them sel ves eit her sin gu lar ly or 
col lec ti ve ly to stron gly in fl uen ce ma ny la bo ra to ry 
re sul ts and the re by aff e ct the diag nos tic out co me, 
the fol low-up or even the treat me nt of the pa tien-
ts (35). The cli ni cal la bo ra to ry re sul ts are an es sen-
tial pa rt of the heal thca re de li ve ry. It has been es ti-
ma ted that 60 up to 70% of me di cal de ci sio ns and 
pro ce du res, su ch as drug pres crip tio ns, as ses smen-
ts prior to and in the cour se of fur ther in ves ti ga tio-
ns or dia lysis, are stron gly de pen de nt upon la bo-
ra to ry da ta (36). As re por ted, sel dom the expe rt 
phle bo to mi st con clu des the col lec tion of diag nos-
tic blood spe ci me ns wit hin sixty se con ds of tour-
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pro tei ns su ch as to tal cal cium, mag ne sium, so-
dium, po tas sium and phos pha te. As shown in Tab-
le 1, the con cen tra tion of glu co se in the sam ples 
col lec ted wi th tour niquet was sig ni fi  can tly hig her 
when com pa red to tran sil lu mi na tion de vi ce from 
G2 to G4. On ly in group G5 a re ver sal of this eff e ct 
was ob ser ved and cli ni cal ly sig ni fi  ca nt diff e ren ces 
we re ap pa re nt. We hypot he si zed that glu co se un-
der goes two si mul ta neous and an ta go nis tic eff ec-
ts in res pon se to ve nous sta sis. When ve nous sta sis 
had sho rt du ra tion, as re com men ded by CLSI (≤ 60 
sec) (12), glu co se in crea sed slig htly in res pon se to 
lo cal he mocon cen tra tion. Du ri ng is che mia, as the 
ar ti fi  cial one due to pro lon ged tour niquet ti me, 
glu co se up ta ke and ce ll glyco lysis are pre va le nt 
mec ha nis ms (40-42). When the ti me of tour niquet 
ap pli ca tion is pro lon ged (G5), glyco lysis do mi na-
tes, thus pro mo ti ng a sig ni fi  ca nt re duc tion in the 
con cen tra tion of this ana lyte, ab le to aff e ct cli ni cal 
in ter pre ta tion. This fi n di ng is in ag ree me nt wi th 
the stu dy by Lip pi et al. (15) who al so ob ser ved a 
cli ni cal ly sig ni fi  ca nt re duc tion in blood glu co se af-
ter 3 mi nu tes of tour niquet ap pli ca tion. Hi gh mo-
le cu lar weig ht mo le cu les li ke pro tei ns, rep re sen-
ted in our stu dy by al bu min, to tal pro tein and al ka-
li ne phos pha ta se showed the expec ted per for-
man ce (increa sed con cen tra tion, pro por tio nal ly to 
the ve nous sta sis ti me). All of the se bio mar ke rs in-
crea sed sig ni fi  can tly and prog res si ve ly amo ng G2 
to G5 in sam ples ob tai ned usi ng tour niquet. Star ti-
ng from G2, the cli ni cal sig ni fi  can ce for to tal pro-
tein and al bu min ap pea rs diff e re nt. Al ka li ne phos-
pha ta se shows simi lar chan ge on ly in G5. The abo-
ve di ver gen ce cou ld be explai ned by the hi gher 
bio lo gi cal va ria bi li ty of al ka li ne phos pha ta se in 
res pe ct of to tal pro tein and al bu min, whi ch pro du-
ces a lar ge va ria tion in re sul ts. Our re sul ts are com-
pa rab le wi th tho se of Lip pi et al. (15) for al bu min 
and the be ha vior of ALT en zyme stu died by the se 
aut ho rs is si mi lar to our da ta on alka li ne phos pha-
ta se. Si mi lar stu dies ha ve shown that plas ma fi b ri-
no gen (39), and he mog lo bin (38) con centra tion in 
who le blood had a si mi lar res pon se, su ch as that 
ob ser ved for to tal pro tein and al bu min.
Se rum le ve ls of trig lyce ri des, showed a prog res si-
ve and sig ni fi  ca nt in crea se wi th in crea si ng ti me of 
tour niquet from G2 to G4; this is the expec ted be-
ha vior for a mo le cu le as so cia ted main ly wi th a lar ge 
niquet ap pli ca tion or even mo re (18). Seve ral con-
cur re nt cau ses mig ht con tri bu te to len gthen the 
tour niquet ti me even over 3 mi nu tes, su ch as a dif-
fi  cu lt lo ca tion of an ap prop ria te ve nous ac ce ss, the 
se lec tion of the mo st sui ted blood col lec tion sys-
tem, the in ser tion of the need le in to the vein, the 
col lec tion of ma ny tu bes, etc (3,5,6,10,15-17).
From a prac ti cal poi nt of view, the tour nique t-in-
du ced ve nous sta sis pro mo tes the exit of wa ter, 
diff u sib le io ns and low mo le cu lar weig ht sub stan-
ces from the ves sel the re by in crea si ng the con cen-
tra tion of va rious blood ana lytes at the pun ctu red 
si te thus po ten tially in fl uen ci ng the la bo ra to ry re-
sul ts in ter pre ta tion. Mo re so, when the vas cu lar 
mic roen vi ron me nt is sub jec ted to bo th hypoxia 
and con cur re nt sta sis, ac cu mu la tion of so me biop-
ro duc ts en sues su ch as pro to ns that ha ve the po-
ten tial to pro mo te chan ges in la bo ra to ry pa ra me-
te rs (37). Thus, the use of tour niquet has the po-
ten tial to gene ra te fal se po si ti ve re sul ts and pros-
pec ti ve ly in du ce the ca ri ng physi cia ns to ado pt 
un due treat men ts. On the con tra ry, TD is ab le to 
eli mi na te or great ly re du ce the se ris ks on he ma to-
lo gi cal (38) and coa gu la tion (39) la bo ra to ry tes ts. 
In or der to deal wi th so me of the abo ve is sues, the 
qua li ty la bo ra to ry ma na ger shou ld de vi se and 
ado pt im pro ved blood col lec tion pro ce du res cha-
rac te ri zed by the lea st pos sib le ve nous sta sis, e.g., 
by im ple men ti ng TDs af ter ac cu ra te re-e va lua tion 
of the who le blood col lec tion pro ce du res car ried 
out by phle bo to mis ts (7). Mo reo ver stu dies 
showed that pro ce du res re la ted wi th phle bo to my 
ha ve diff e re nt qua li ty per for man ce in priva te and 
pub lic hos pi ta ls (9) or la bo ra to ries (18) res pec ti ve-
ly. Our re sul ts showed that TD as sis ted phle bo to-
my can po si ti ve ly act on the se heal th ca re re la ted 
is sues by bo th im pro vi ng the phle bo to my pro ce-
du res and pro mo ti ng pa tie nt and ope ra tor sa fe ty. 
To bet ter il lus tra te the abo ve sta te men ts, we ana-
lyzed glu co se, a mo le cu le ve ry so lub le in wa ter 
and wi th low mo le cu lar weig ht, and pro tein struc-
tu res of diff e re nt mo le cu lar weig ht su ch as al bu-
min, to tal pro tein and al ka li ne phos pha ta se. Mo-
reo ver eit her trig lyce ri de le ve ls we re eva lua ted in 
or der to mo ni tor the eff e ct of tour niquet on sub-
stan ces car ried by lar ge par tic les su ch as li pop ro-
tein VLDL (ve ry low den si ty li pop ro tein) or elec tro-
lytes wi th diff e re nt deg rees of in te rac tion wi th 
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par tic le of VLDL. The hi gh bio lo gi cal va ria bi li ty of 
this ana lyte (CVw 28.2%) (43) may explain the ab se-
n ce of cli ni cal ly sig ni fi  ca nt chan ges in the se grou ps.
Unexpec ted ly, in the G5 trig lyce ri de con cen tra tion 
sig ni fi  can tly was re du ced in sam ples sub jec ted to 
pro lon ged ve nous sta sis wi th a cli ni cal ly sig ni fi  ca-
nt eff e ct. Our hypot he sis is that the com plex mi-
lieu crea ted by pro lon ged ve nous sta sis, hypoxia 
and aci do sis was ab le to sti mu la te the ra pid deg ra-
da tion of trig lyce ri des that we re mo bi li zed to pro-
vi de ener gy to the tis sue in res pon se to re du ced 
synthe sis of ATP from glu co se oxi da tion. Stu dies of 
se rum trig lyce ri des in res pon se to mo de ra te hy-
poxia is che mia poi nt to the sa me di rec tion (44,45).
For to tal cho les te rol, tran spor ted in plas ma main ly 
by LDL, a par tic le sig ni fi  can tly smal ler than VLDL, 
Lip pi et al. (15) ob ser ved a sig ni fi  ca nt in crea se on ly 
af ter 3 mi nu tes of tour niquet.
The ca tio ns, cal cium and mag ne sium, are stron gly 
as so cia ted wi th pro tei ns, whi ch may explain the 
tre nd to in crea se du ri ng tour niquet ap pli ca tion si-
mi lar to to tal pro tein and al bu min, and cli ni cal ly 
sig ni fi  ca nt from G2 to G5. The be ha vior of cal cium 
ob ser ved is si mi lar to that des cri bed by Lip pi et al. 
(15) for tour niquet ti me ap pli ca tion du ri ng 60 sec 
and 180 sec. The be ha vior of se rum so dium and 
po tas sium com pa red to ve nous sta sis ob ser ved in 
this stu dy di ver ged from the re po rt by Lip pi et al. 
(15). We sug ge st that the in crea se of po tas sium 
due to venous sta sis is re la ted to lo cal aci do sis re-
sul ti ng from this pro ce ss, the pro ton bei ng in ter-
na li zed in to the ce ll and rep la ced by po tas sium, 
whi ch wou ld in crea se its plas ma le ve ls (37). Amo-
ng the pa ra me te rs that pre sen ted the hig he st sta-
bi li ty again st ve nous sta sis was the se rum phos-
pha te con cen tra tion. On ly af ter three mi nu tes 
tour niquet we re ele va ted con cen tra tio ns of phos-
pha te iden ti fi ed. The re is not a cau sal expla na tion 
at pre se nt for the per for man ce of this ana lyte. So-
me of the abo ve eff e cts of ve nous sta sis ap pear 
con tro ver sial amo ng diff e re nt stu dies. Mo reo ver 
the per for man ce and coeffi   cie nts of ana lyti cal va-
ria tion of diff e re nt ana lyti cal in stru me nt can diff e-
re ntly in fl uen ce the va ria bi li ty of pa ra me te rs su ch 
as trig lyce ri des that ap pear res pon sib le for the 
abo ve diff e ren ces ob ser ved be tween our study 
and Lip pi et al. (15).
On the ot her ha nd it is clear the eff e ct of tour-
niquet on la bo ra to ry pa ra me te rs wi th diff e re nt 
struc tu ral cha rac te ris ti cs and physi co-che mi cal 
pro per ties. The pos si bi li ty of eli mi na ti ng this sour-
ce of va ria tion throu gh lo ca tion of veins by tran sil-
lu mi na tor de vi ce shows the po ten tial to eli mi nate 
this sour ce of er ror. In sum ma ry, our re sul ts show 
that ve nous sta sis crea ted by the use of tour niquet 
aff e cts rou ti ne tes ts and that tran sil lu mi na tor de vi-
ce han dli ng can be an eff ec ti ve met hod to eli mi-
na te this sour ce of prea na lyti cal va ria tion.
The abo ve re sul ts do ob vious ly ap ply on ly to our 
expe ri men tal de si gn, even thou gh they cou ld rep-
re se nt a viab le ba sis for the go ver nan ce of the 
prea na lyti cal va ria bi li ty re la ted to sam ple sta sis. 
Fur ther stu dies are nee ded in or der to va li da te the 
use of TD as for pos sib le aid in re du ci ng the hae-
mo lytic spe ci me ns. Mo reo ver an eva lua tion of TD 
use in pa tien ts wi th cli ni cal con di tio ns ab le to aff e-
ct vein ac ce ss shou ld be de vi sed.
No po ten tial con fl ic ts of in te re st re le va nt to this ar-
tic le we re re por ted.
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No vi na či ni suo ča va nja s poz na tim pri jea na li tič kim pi ta nji ma: prim je na tran si lu mi na to ra 
um jes to pod ve ze za lak ši pris tup ve ni i uk la nja nje staze kr vi u kli nič koj bio ke mi ji
Sažetak
Uvod: Prim je na pod veze mo že zbog nas ta ja nja ven ske sta ze pro mi je ni ti kon cen tra ci je i/ili ak tiv nos ti ne ko li ko ana li ta u kr vi, no vr lo se ri jet ko smat ra 
jed nim od uz ro ka la bo ra to rij ske va ri ja bil nos ti. Ka ko bi se to prev la da lo, pred la že se prim je na tran si lu mi na to ra (en gl. tran sil lu mi na tion de vi ces, TD) kod 
va đe nja kr vi za spre ča va nje nas tan ka ven ske sta ze. U ovom smo član ku is pi ta li prim je nu tran si lu mi na to ra um jes to pod ve ze ti je kom va đe nja kr vi.
Ma te ri ja li i me to de: Uzor ci kr vi pri kup lje ni su od 250 dob ro vo lja ca po di je lje nih u pet ho mo ge nih sku pi na pre ma to me ko li ko su du go ima li 
pod ve zu na ru ci (G1: 30 sekun di, G2: 60 sekundi, G3: 90 sekun di, G4: 120 sekundi, G5: 180 sekun di) te su us po re đe ni s uzor ci ma do bi ve nim prim-
je nom TD. U sva kom je uzor ku od re đe na kon cen tra ci ja glu ko ze, uku pnih pro tei na, al bu mi na, trig li ce ri da, ka li ja, nat ri ja, fos fa ta, kal ci ja, mag ne zi ja 
i ak tiv no st al kal ne fos fa ta ze.
Re zul ta ti: Iz me đu uzo ra ka pri kup lje nih nakon prim je ne TD i sku pi ne G1 ni je na đe na sta tis tič ki zna čaj na raz li ka ni ti kod jed nog kli nič kog tes ta; 
kod sku pi ne G2 je kon cen tra ci ja glu ko ze, uku pnih pro tei na, al bu mi na, trig li ce ri da, ka li ja, kal ci ja, mag ne zi ja i ak tiv no st al kal ne fos fa ta ze bi la po-
vi še na. Kod sku pi na G3 i G4 ni je na đe no sta tis tič ki zna čaj no po vi še nje kon cen tra ci je osim kod kon cen tra ci je fos fa ta. Kod sku pi ne G5 na đe no je 
sta tis tič ki zna čaj no po vi še nje kon cen tra ci je/aktivnosti kod svih is pi ta nih ana li ta. Na da lje, kod sku pi na G2, G3, G4 i G5 pri mi je će ne su kli nič ki zna-
čaj ne va ri ja ci je za kon cen tra ci ju uhup nih pro teina, al bu mina, ka lija i kal cija; u sku pi na ma G3, G4 i G5 za kon cen tra ci ju nat ri ja; u sku pi na ma G4 i G5 
za kon cen tra ci ju mag ne zi ja te u sku pi ni G5 za kon cen tra ci je glu ko ze i trig li ce ri da te ak tiv no st al kal ne fos fa ta ze.
Zak lju čak: Do bi ve ni re zul ta ti go vo re u ko ri st prim je ne TD pri li kom va đe nja kr vi za ru tin ske bio ke mij ske la bo ra to rij ske tes to ve te pred la žu nje go-
vu učes ta li ju prim je nu.
Ključ ne ri je či: fl e bo to mi ja i pri kup lja nje uzo ra ka kr vi; pri jea na li tič ka fa za; sus tav up rav lja nja kva li te tom u kli nič kom la bo ra to ri ju; tran si lu mi na-
ci ja; ven ska sta za
